• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.6249 -0.0151 (-2.36%)
Streaming Delayed Price Updated: 12:07 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,858,500
Open 0.6300
Bid (Size) 0.6246 (5)
Ask (Size) 0.6249 (49)
Prev. Close 0.6400
Today's Range 0.6114 - 0.6500
52wk Range 0.4111 - 3.179
Shares Outstanding 145,337,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sangamo Therapeutics Inc (NASDAQ:SGMO) Reports Q2 2025 Earnings: Revenue Misses but Narrower-Than-Expected Loss
August 07, 2025
Sangamo Therapeutics (SGMO) reported Q2 2025 results with revenue missing estimates at $18.31M but a narrower loss of $0.08/share. Shares fell 9% post-earnings despite positive Fabry disease trial... 
Via Chartmill
Earnings Scheduled For August 7, 2025
August 07, 2025
 
Via Benzinga

Performance

YTD
-44.7%
-44.7%
1 Month
+21.5%
+21.5%
3 Month
+29.4%
+29.4%
6 Month
-11.4%
-11.4%
1 Year
-37.0%
-37.0%

More News

Read More
Tuesday's pre-market session: top gainers and losers
June 24, 2025
Via Chartmill
Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
June 24, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For May 12, 2025
May 12, 2025
Via Benzinga
These stocks are moving in today's session
May 13, 2025
Via Chartmill
Tuesday's session: top gainers and losers
May 13, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 13, 2025
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
May 13, 2025
Via Chartmill
Which stocks are moving before the opening bell on Tuesday?
May 13, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 13, 2025
Via Benzinga
US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert
May 13, 2025
Via Benzinga
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
May 13, 2025
Via Benzinga
Which stocks are moving after the closing bell on Monday?
May 12, 2025
Via Chartmill
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results
May 12, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering
May 12, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
May 12, 2025
Via Benzinga
Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day
May 12, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
May 06, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
May 06, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 28, 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
Friday's pre-market session: top gainers and losers
April 04, 2025
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 04, 2025
Via Benzinga
US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert
April 04, 2025
Via Benzinga
Topics Government
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
April 04, 2025
Via Benzinga

Frequently Asked Questions

Is Sangamo Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sangamo Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sangamo Therapeutics, Inc. - Common Stock trade on?
Sangamo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sangamo Therapeutics, Inc. - Common Stock?
The ticker symbol for Sangamo Therapeutics, Inc. - Common Stock is SGMO on the Nasdaq Stock Market
What is the current price of Sangamo Therapeutics, Inc. - Common Stock?
The current price of Sangamo Therapeutics, Inc. - Common Stock is 0.6249
When was Sangamo Therapeutics, Inc. - Common Stock last traded?
The last trade of Sangamo Therapeutics, Inc. - Common Stock was at 10/17/25 12:07 PM ET
What is the market capitalization of Sangamo Therapeutics, Inc. - Common Stock?
The market capitalization of Sangamo Therapeutics, Inc. - Common Stock is 90.82M
How many shares of Sangamo Therapeutics, Inc. - Common Stock are outstanding?
Sangamo Therapeutics, Inc. - Common Stock has 91M shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap